Abstract
Introduction
Substance use disorder (SUD) is characterized by a problematic pattern of substance use leading to clinically significant impairment or distress [1] . Substance dependency involves a spectrum of physiological, behavioral, and cognitive alterations, where the use of a substance or substance class is prioritized over other behavior that was previously of value for the individual [2] .
People who develop a dependency may seek help from specialized services. Several studies show an elevated frequency of cognitive impairment among treatment-seek-ing populations [3] [4] [5] , with prevalence estimates varying between 20 and 80% for abusers of alcohol and drugs [6, 7] . Clinically important factors, including an increased risk of treatment dropout [8] and low treatment adherence [9] , have been associated with cognitive impairment in treatment-seeking SUD populations.
Considering global cognitive functioning, clinical interpretation of sub-average intelligence coefficient (IQ) results in persons with SUD can be difficult, as there is currently no consensus on whether these results are a function of substance use or are related to factors independent of SUD. In a normal, developmental model of IQ, the following factors have been found to influence adolescent and adult IQ: childhood cognitive functioning [10] , childhood IQ [11, 12] , hereditability [13] , and education [14] [15] [16] . Shared environment, including socioeconomic status, have also been widely studied, but the evidence of its effect on adult IQ beyond 20 years of age is still uncertain [17, 18] . Studies of individuals with SUD have proposed that substance use can disturb the normal developmental course of intelligence and cause partial developmental deviations [19] , including temporary decline [20] and even persistent decline in IQ [21] .
Models of the relationship between SUD and deviant intelligence often comprise factors related to the substances used and user behavior such as age of onset [21, 22] , type of substance used or polydrug use [19] [20] [21] [22] , ongoing or recent substance use [23, 24] along one dimension, and environmental and constitutional factors along another. The latter includes genes and shared environment [25] , socioeconomic status [26, 27] and childhood problems, including mental illness, cognitive difficulties and lower academic achievement preceding SUD [28] [29] [30] [31] [32] . Also, several of these environmental and constitutional factors have been associated with early school leaving [33, 34] . Thus, giving rise to education as a mediator between background factors, influencing both substance use and lower or declining IQ in the SUD population.
Methodological limitations make findings from previously conducted clinical studies difficult to interpret and generalize. Many studies have used parts of standardized IQ tests [19, 22, [35] [36] [37] [38] , thus providing results that might not reflect global intellectual functioning but rather an area or domain of intellectual functioning. The timing of IQ testing has varied greatly among previous studies, with some only requiring abstinence on the day of testing [27, 39] or within the first days after admission [38] . Therefore, their results might reflect the acute/post-acute effects of substance use rather than a permanent or stable IQ. There is also a general lack of research focused on IQ in the clinical SUD population independent of substances used or in relation to severity of use, including polydrug use, which is a common condition among service users [40] . There is a need for further studies and knowledge regarding which factors might explain the observed IQ in service users with SUD.
Following a model of normal IQ development in combination with suggested explanations for deviant IQ in people with SUD, the aim of the current study was to investigate the direct and indirect effects of childhood difficulties on IQ in in-patients with mixed user profiles. We postulate 2 possible mediating pathways: through education and through the severity of substance use.
Material and Methods

Participants
The sample included in-patients in treatment for SUD. The following inclusion criteria were used: patients over the age of 18 whose native language was Norwegian. Participants who were clinically judged to be under the influence of drugs/alcohol or showing signs of severe mental illness, such as psychosis, dissociation, extreme anxiety or major depression at the time of testing were excluded. Further exclusion criteria were as follows: those abstinent from substance use for less than 6 weeks and individuals who had been administered the Wechsler Adult Intelligence Scale during the last 6 months.
Procedures
Participants were recruited from 3 in-patient adult specialized health service institutions for drug and alcohol abuse. Five treatment facilities for SUD were invited to participate in the study. Three of these institutions were included based on their willingness. All 3 institutions were part of the public health-care system, two being owned by the local health authorities and one being a private institution under an operating agreement with the local health authorities. Among those who declined, one was a private institution with operating agreement and one was owned by the local health authorities. In Norway, in-patient treatment for SUD is free of charge for individuals both in public institutions and private institutions under operation agreement with the local health authorities. Individuals in need of in-patient treatment can freely choose which institution they want to be referred to, private or public. All Norwegian SUD institutions have to follow national treatment recommendations/guideline. Data was collected from the participating institutions. No compensation was provided to either participants or the institutions, and all participants gave informed consent. The Regional Ethical Committee for Medical Research in Norway (REK) approved the study (REK reference: 2011-00778).
Patients were asked to participate in the study at the time of admission for treatment. An assessment appointment was set at least 6 weeks from last substance intake. Participants were given a participant questionnaire, which covered the patient's history of substance use and childhood difficulties, and were asked to bring the completed questionnaire to the assessment appointment.
At the assessment appointment, a clinical psychologist or clinical psychology student administered the IQ test. Abstinence from substance use was ensured through urine samples and clinical observation.
Measures
IQ
The Wechsler Adult Intelligence Scale -Fourth Edition (WAIS-IV) was used to measure the participants' IQs. This is an individually administered psychological measurement instrument that judges the intellectual capacity of people between 16 and 89 years. In addition to full-scale IQ (FSIQ), IQ can be interpreted through the following 4 indexes: verbal comprehension index (VCI), perceptual reasoning index (PRI), working memory index (WMI), and processing speed index (PSI). In the present study, the Norwegian version with Scandinavian norms was used [41] .
All WAIS-IV assessors were trained in the use and scoring of subtests and were given practical exercises in a 3-day course. The training was provided by a clinical psychologist specialized in addiction psychology and trained in the administration and interpretation of the WAIS-IV. In addition, assessors individually scored the same videos of 9 patients' responses to 4 randomly selected WAIS-IV subtests. Intraclass correlation (ICC) analyses were calculated, and ICCs between 0.84 and 1.0 implied almost perfect consistency in scoring among raters [42] .
Substance Use: Diagnosis and Severity of Use The diagnosis of substance use and comorbid mental illness was performed through standard clinical procedures at the treatment facilities. This included clinical interviews and structured measures such as the M.I.N.I International Neuropsychiatric Interview (M.I.N.I) and Structured Clinical Interview for DSM disorders. A substance use disorder or mental illness was diagnosed when the participant met the criteria for a disorder according to the International Classification of Diseases 10th edition (ICD-10) [2] . Diagnosis was recorded by the treating psychologist or physician on a therapist questionnaire at the end of treatment.
Participants reported past and current substance use on the participant questionnaire. Questions on recent and current use were derived from a national questionnaire for all patients registered in SUD treatment in Norway [43] . A severity of substance use index was calculated from 5 dichotomous items. Each participant's severity of use was scored on a scale from 0 to 5, where 5 indicates the most severe use with positive answers on all items. Table 1 for the items and response frequency. The severity of use index yielded a mean score of 3.11 (SD = 1.12).
Childhood Difficulties and Level of Education Information about childhood functioning and level of completed education was derived from the participant questionnaire. Items on childhood functioning were based on the ICD-10 criteria and the characteristics of different childhood difficulties. Based on content and face validity, childhood items were grouped in 5 domains: learning difficulties (LD), attention deficit/hyperactivity (A/H), affective problems (AF), conduct problems (CP), and social difficulties/stereotypic behavior (SS). As the ratio of sample-to-items was low, a rigorous test of dimensionality could not be conducted in the current study. Still, for heuristic purposes, the proposed 5-factor model was tested using confirmatory factor analysis. This analysis suggested adequate model fit (comparative fit index = 0.902; root mean square error of approximation = 0.044). Online supplementary Appendix Table S1 (see www.karger.com/doi/10.1159/000486620), for items and response frequency.
Statistics
All statistical analyses were done using the statistical software package SPSS 23. To test whether the sample was to be treated as homogenous or heterogeneous with regards to substance use, analyses of variance were run for variance among groups based on the substance most used in the last 6 months.
Mediation models were tested using the PROCESS SPSS macro [44] . In the multiple mediation models, the effect of childhood problems on IQ was mediated through the severity of substance use (substance pathway) and education (education pathway). Separate models were run for each of the 5 problem domains. The PROCESS module decomposes the effects into indirect (ab), direct (c'), and total effects (c). Mediation was tested through bootstrapped ab products and Sobel tests [45] .
PROCESS assumes complete data and uses list-wise deletion of missing data.
Results
Recruitment and Participant Flow
One hundred and twenty-six patients were asked to participate during the recruitment period 2013-2015. Of those, 13 declined (10 men), 3 met the exclusion criteria (1 man), and 16 dropped out due to drug-use relapse (11 men). Of the remaining 94 participants, 90 completed the WAIS-IV, 92 completed the therapist questionnaire, and 84 returned a partially or fully completed participant questionnaire, 64 of these with information on childhood functioning. Thus the final sample eligible for analysis was 90 for IQ, and 64 for the mediation analysis. Description of the Sample Of the 90 participants included, 64.4% were men and 35.6% are women. Their mean age was 33.27 (range 19-64, SD = 11.50). Their highest completed education was as follows: primary school (1st-6th grade) 5.6%, secondary school (7th-9th grade) 43.3%, further education (10th-12th grade) 34.5% and higher education (e.g., university) 0%. Of the participants, 5.6% received their main income from employment, and the rest received their main income from different types of social benefits and disability pensions, 10% had missing information on income. The median age for the first episode of substance use was 14 (range 8-18). The median age for regular substance use was 16 (range . Among the participants, 53.3% had 1 or more comorbid psychiatric illnesses (ICD-10 F20-F90). Regarding SUD diagnosis, 36.7% had 1 diagnosis of substance use, 62.2% met the criteria for 2 or more diagnoses of substance use. One person had missing information of substance use and mental illness diagnosis. An overview of ICD-10 diagnoses on substance use is presented in Table 2 . It should be noted that diagnosing tobacco addiction is not common in Norway, although many in SUD treatment probably meet the criteria. 
IQ Distribution in the Sample
Effects of Childhood Difficulties, Education and Severity of Substance Use on Adult IQ
Multiple mediation analysis was done using the PRO-CESS SPSS macro (n = 64). All 5 models examined whether the effect of childhood difficulties on IQ was mediated through fewer years of education and/or more severe substance use. Separate mediation analysis was run for all the indexes and FSIQ. All analysis was controlled for age and gender. Table 3 provides an overview of the mediation models and results. Model 4. Social Difficulties/Stereotypical Behavior There was no statistically significant total, direct, or indirect effect of childhood SS or the mediators on any of the IQ measures. Model 5. Affective Problems There was no statistically significant total, direct, or indirect effect of AF or the mediators on any of the IQ measures.
Education, controlled for childhood difficulties, had a univariate statistically significant effect on VCI in all 5 mediation models and on FSIQ in 2 of the models (SS and AF). Severity of substance use did not have a univariate influence in any of the models.
Discussion
The main findings were that LD and A/H in childhood were directly related to adult IQ, indicating that the more severely a participant experienced these difficulties as a child, the lower that participant's in-treatment IQ. This influence was shown for the FSIQ, WMI and PSI. Education had a mediating effect between some of the childhood difficulties and VCI, showing that higher LD and CP in childhood lead to fewer years of education, which again results in lower VCI. Education also had a mediating effect between CP and FSIQ. There was no significant difference in IQ due to the specific substance used, and the average IQ of the sample population was lower than the global average. The severity of substance use did not influence IQ in any of the models tested.
As for IQ variance within the SUD group, the results suggest different trajectories to the observed variation of IQ in in-patients with SUD. One trajectory is through the direct effect of childhood difficulties (FSIQ, WMI and PSI), and another is through the indirect effect of childhood difficulties via education (VCI and FSIQ).
The finding that prior LD had a direct effect on intreatment IQ level is expected from a developmental view. According to the ICD-10, intellectual disabilities are conditions of the delayed or deficient development of cognitive, language, motor and/or social abilities [2] . In addition, the narrower domains of WMI and PSI were significant, reflecting poorer cognitive efficiency [46] in those who reported general LD in childhood. WMI was also directly correlated to attention-deficit/ hyperactivity difficulties in childhood, and this finding is in accordance with previous findings on studies of individuals with attention-deficit/hyperactivity disorder [41, 47] .
The second trajectory was the indirect effect of childhood difficulties via the mediator of education. Verbal IQ has traditionally been linked to the length of education [48] . Both learning disabilities and conduct-related problems have previously been found to increase the risk of dropping out of school [34, [49] [50] [51] . Learning disabilities are also strongly correlated with low academic achievement [34] , and several studies have found that low academic achievement in school predicts school dropout [33, 34] . Hickman et al. [50] concluded that differences in learning and academic achievement between high school dropouts and graduates can be traced back to kindergarten, indicating that people tend to follow a developmental pathway set early on.
The finding that the average IQ of the sample population was lower than the global average could be explained by the population's use of alcohol or drugs reflecting a neurotoxic short-or long-term effect of substance use. Following this line, normal intellectual functioning should be observed if the participants never used substances. However, this is unlikely, as the group is different in other areas associated with lower IQ in the general population, such as lower education and socioeconomic status [14] [15] [16] [17] . These factors have also been linked to IQ in the SUD population [27] . Comparing key figures from Statistisk sentralbyrå/Statistics Norway, both education and income from employment were considerably lower in the studied population than in the general population [52, 53] . One could argue that substance use in itself may affect the length of education and through its effect on education, again affect both IQ and socioeconomic status. However, our results show that school dropout (median age 14) precedes the onset of regular substance use (median age 16) and others that VCI is not only correlated to own socioeconomic status but also to their parents' [27] , strengthening the pre-use hypothesis of lower IQ in the SUD population compared to the general population. Thus, common risk factors for low IQ on a group level are also applicable to the subpopulation of individuals with SUD, and the principle of scientific parsimony may be applied. It should be noted that our study population of inpatients with SUD may differ from other populations of SUD such as outpatients or non-treatment seeking individuals, and that the risk factors may be lower and the average IQ on a group level therefore being higher in other SUD subpopulations.
Our results support previous studies that have found environmental and constitutional factors as explanations for deviant IQs in people with SUD. We fail to find an effect of substance type used or severity of use as found in other previous studies [19] [20] [21] [22] previous studies have different designs, methods, and study populations, and thus a direct comparison of results is difficult.
There are several strengths in the present study. The most important is the use of the complete WAIS-IV for assessing intelligence. Further, by restricting testing to 6 weeks of abstinence, the acute and most post-acute effects of substance use were eliminated. The study also used a comprehensive severity of use index based on substance-related factors associated with deviant IQ in individuals with SUD from previous studies. Finally, all participants were diagnosed by a licensed psychologist or physician using the ICD-10 classification system. Despite these strengths, some limitations of this study must also be mentioned. Given the present design, caution must be used when interpreting the direction of findings. We cannot exclude the possibility that a participant's current situation biased his/her description of childhood functioning, or that the level of IQ influences the way one reports childhood difficulties. Also, by using a scale for childhood functioning that has not been independently validated, one should interpret our results with caution. Our findings could have been strengthened by including additional information on childhood functioning from school records and/or parent and teacher interviews. However, based on the face validity and confirmatory factor analysis of the participants' childhood difficulties, it is our conclusion that these limitations do not threaten the main findings in the present study.
The inclusion of syringe use in the severity of use index excludes some addiction categories from having the opportunity to achieve a maximum score on the index, such as those with only alcohol or cannabis addiction. However, the frequency of polydrug use was high and the frequency of syringe use was low in this sample, so it is not likely that the restriction on the data due to this limitation was significant.
Although our study population is considered representative of service users with a diagnosis of SUD [40] and represents a reasonably large clinical sample, the number of participants in each substance-use group was low. This means our conclusions are on a general level and not on a more detailed substance-by-substance level, which could yield additional information on nuances within the SUD population. Also, our study did not have a non-user control group with matched childhood difficulties and duration of schooling, which could have provided information on possible groupspecific differences. We cannot rule out the possibility that substance-related factors would have influenced IQ in a larger sample as mediation analysis is sensitive to a low N.
A larger sample would have enabled a more comprehensive and multivariate modeling approach, and allow for inclusion including multiple background variables in the overall model. Given the sample size, a restrictive modeling approach had to be followed, resulting in multiple specific models, and potentially, increased need for controlling the family-wise error rate. Based on these considerations, our results are preliminary and should be interpreted with caution. Yet we believe that the results provide sufficient evidence for the hypothesis that IQ in inpatients with SUD is related to childhood difficulties and education, and future studies should examine this closer with more rigorous methods.
In summary, our study indicates that after 6 weeks of abstinence from substance use, neither the type of substance used nor the severity of substance use influences IQ variance among in-patients with SUD. Our finding that childhood difficulties influence in-treatment IQ is in accordance with previous studies that have found environmental or constitutional factors as explanations for deviant IQ among individuals with SUD. The results fit a normal theory of IQ development with commonly known risk factors and no disturbing effect of substance use. Our results show that on a group level in-patients with SUD may have lower than average intellectual abilities. To assess the risk of dropout and ensure better individualized substance use treatment, screening for global cognitive functioning or IQ should be conducted for all service users. Initial consultations should include questions about childhood functioning and academic achievement/length of schooling. Inquiries about childhood LD are of importance, as are A/H and conductrelated problems.
